The deal disrupts a long-established practice of the exemption of medicines from tariffs due to their importance in public ...

President Donald Trump threatened to levy tariffs of up to 250% on pharmaceuticals imported into the United States.

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

The tariffs are Trump’s way of getting drug companies to move more of their operations to the U.S. at a time when domestic ...

Stealth BioTherapeutics, which has been developing a rare disease drug, said it is making contingency plans to close the ...

On his part, Madbouly emphasized that this meeting aims to follow up on efforts to advance the pharmaceutical industry ...

Welcome to Contract Pharma’s annual ranking of the Top 20 Pharma and Biopharma Companies, based on fiscal year 2024 ...

While there’s been limited action in Congress on marijuana legislation so far this year, that hasn’t stopped a variety of ...

President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

HPMA hails Lalit Goel's promotion as state drugs controller- cum-Licensing Authority: Peethaambaran Kunnathoor, Chennai ...